ARMISTICE CAPITAL, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Voyager Therapeutics, Inc. Common Stock, $0.001 par value (SCLX)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Voyager Therapeutics, Inc. Common Stock, $0.001 par value
Symbol: SCLX
Shares outstanding: 55,491,329 shares
Disclosed Ownership: 4,800,000 shares
Ownership: 8.65%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 21:40:36 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	8.65%	4,800,000	0	4,800,000	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	8.65%	4,800,000	0	4,800,000	/s/ Steven Boyd	Steven Boyd